Biologics Outsourcing Market Overview, Growth Factors, Demand, Trends and Forecast to 2028

By Ashwin Naphade  | Date: November 01, 2022

Biologics Outsourcing Market Overview, Growth Factors, Demand, Trends and Forecast to 2028

An analysis of Biologics Outsourcing Market has been provided in the latest report added by Market Study Report that primarily focuses on the market trends, demand, and future prospects of this industry over the forecast period. Furthermore, the report provides a detailed statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share.

The global biologics outsourcing market is expected to grow at a CAGR of around 12.5% over the forecast period. The market growth is attributed to the increasing adoption of advanced technologies for biological production, a rise in outsourcing of R&D activities by pharmaceutical and biopharmaceutical companies and a favorable regulatory environment for clinical trials in developing countries. Further, the increase in the number of mergers and collaborations has increased pharmaceutical and biopharmaceutical outsourcing, with major industry players expanding into developing regions. For instance, in May 2019, Thermo Fisher Scientific, Inc. acquired Brammer Bio, a viral vector contract developer for gene and cell therapies, to strengthen its market position in the area of gene therapy.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5517000/

Market Segmentation

The global biologics outsourcing market has been analyzed on the basis of product type, source, application, end-use, and region. Based on the product type, the market is segmented into antibodies, recombinant proteins, vaccines, and others. Among these, antibodies segment is estimated to hold a prominent share in the market. Based on source, the market is segmented into human, microbial, and others. The microbial segment is projected to exhibit a considerable growth during the forecast period.

Based on application, the market is segmented into stem cell research, vaccine and therapeutics development, blood & blood-related products development, cellular and gene therapy products development, and others. Stem cell research segment is estimated to hold a prominent share in the market. Based on end-user, the market covers the analysis of therapeutics & diagnostics, and research. Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Structure and Competition Landscape

The global biologics outsourcing market is characterized by the presence of significant number of players. Some of the prominent players operating in the market include Lonza Group AG, Wuxi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., Wuxi Biologics (Cayman) Inc., Genescript Biotech Corp., and others. Growing focus on biologics and increasing R&D spending on biologics drugs by these industry players are expected to drive the market. Some of the key developments in the global biologics outsourcing market include:

•             In January 2022, Samsung Biologics agreed to pay US$ 2.3 billion for Biogen's 50% stake in Samsung Bioepis, a joint venture between the two companies. This is aimed to improve Samsung Bioepis' biosimilar development capabilities and future performance in new drug development.

•             In March 2021, WuXi acquired a single-use biologics production plant in Hangzhou, China, from Pfizer Inc.

Key Questions Answered in the Research Report:

1. What is the estimated growth rate for the market?

2. What is the region wise industry size, growth drivers and challenges key market trends?

3. What are the key innovations, technology upgrades, opportunities, in the Market? 

4. What are the leading companies in the Industry and how they perform in Market?

For more details on this report: https://www.marketstudyreport.com/reports/growth-opportunity-analysis-in-the-global-biologics-outsourcing-market

About US:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.

Contact Us:

Ritesh Tiwari

Corporate Sales,

Phone: 1-866-764-2150

Email: [email protected]

About Author

Ashwin Naphade     ibmag.com

Ashwin Naphade

Ashwin is into digital marketing since the last 2 years and has worked on multiple projects across various industries. He likes posting information and knowledge on multiple topics with an objective to create online visibility as well as share his inputs. His interest...

Read More